1qg6

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1qg6" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qg6, resolution 1.90&Aring;" /> '''CRYSTAL STRUCTURE OF...)
Line 1: Line 1:
-
[[Image:1qg6.jpg|left|200px]]<br /><applet load="1qg6" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1qg6.jpg|left|200px]]<br /><applet load="1qg6" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1qg6, resolution 1.90&Aring;" />
caption="1qg6, resolution 1.90&Aring;" />
'''CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN'''<br />
'''CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN'''<br />
==Overview==
==Overview==
-
Triclosan is used widely as an antibacterial agent in dermatological, products, mouthwashes, and toothpastes. Recent studies imply that, antibacterial activity results from binding to enoyl (acyl carrier, protein) reductase (EACPR, EC 1.3.1.9). We first recognized the ability of, triclosan to inhibit EACPR from Escherichia coli in a high throughput, screen where the enzyme and test compound were preincubated with NAD(+), which is a product of the reaction. The concentration of triclosan, required for 50% inhibition approximates to 50% of the enzyme, concentration, indicating that the free compound is depleted by binding to, EACPR. With no preincubation or added NAD(+), the degree of inhibition by, 150 nM triclosan increases gradually over several minutes. The onset of, inhibition is more rapid when NAD(+) is added. Gel filtration and mass, spectrometry show that inhibition by triclosan is reversible. Steady-state, assays were designed to avoid depletion of free inhibitor and changes in, the degree of inhibition. The results suggest that triclosan binds to, E-NAD(+) complex, with a dissociation constant around 20-40 pM. Triclosan, follows competitive kinetics with respect to NADH, giving an inhibition, constant of 38 pM at zero NADH and saturating NAD(+). Uncompetitive, kinetics are observed when NAD(+) is varied, giving an inhibition constant, of 22 pM at saturating NAD(+). By following regain of catalytic activity, after dilution of EACPR that had been preincubated with triclosan and, NAD(+), the rate constant for dissociation of the inhibitor (k(off)) is, measured as 1.9 x 10(-4) s(-1). The association rate constant (k(on)) is, estimated as 2.6 x 10(7) s(-1) M(-1) by monitoring the onset of inhibition, during assays started by addition of EACPR. As expected, the ratio, k(off)/k(on) = 7.1 pM is similar to the inhibition constants from the, steady-state studies. The crystal structure of E. coli EACPR in a complex, with coenzyme and triclosan has been determined at 1.9 A resolution, showing that this compound binds in a similar site to the diazaborine, inhibitors. The high affinity of triclosan appears to be due to structural, similarity to a tightly bound intermediate in catalysis.
+
Triclosan is used widely as an antibacterial agent in dermatological products, mouthwashes, and toothpastes. Recent studies imply that antibacterial activity results from binding to enoyl (acyl carrier protein) reductase (EACPR, EC 1.3.1.9). We first recognized the ability of triclosan to inhibit EACPR from Escherichia coli in a high throughput screen where the enzyme and test compound were preincubated with NAD(+), which is a product of the reaction. The concentration of triclosan required for 50% inhibition approximates to 50% of the enzyme concentration, indicating that the free compound is depleted by binding to EACPR. With no preincubation or added NAD(+), the degree of inhibition by 150 nM triclosan increases gradually over several minutes. The onset of inhibition is more rapid when NAD(+) is added. Gel filtration and mass spectrometry show that inhibition by triclosan is reversible. Steady-state assays were designed to avoid depletion of free inhibitor and changes in the degree of inhibition. The results suggest that triclosan binds to E-NAD(+) complex, with a dissociation constant around 20-40 pM. Triclosan follows competitive kinetics with respect to NADH, giving an inhibition constant of 38 pM at zero NADH and saturating NAD(+). Uncompetitive kinetics are observed when NAD(+) is varied, giving an inhibition constant of 22 pM at saturating NAD(+). By following regain of catalytic activity after dilution of EACPR that had been preincubated with triclosan and NAD(+), the rate constant for dissociation of the inhibitor (k(off)) is measured as 1.9 x 10(-4) s(-1). The association rate constant (k(on)) is estimated as 2.6 x 10(7) s(-1) M(-1) by monitoring the onset of inhibition during assays started by addition of EACPR. As expected, the ratio k(off)/k(on) = 7.1 pM is similar to the inhibition constants from the steady-state studies. The crystal structure of E. coli EACPR in a complex with coenzyme and triclosan has been determined at 1.9 A resolution, showing that this compound binds in a similar site to the diazaborine inhibitors. The high affinity of triclosan appears to be due to structural similarity to a tightly bound intermediate in catalysis.
==About this Structure==
==About this Structure==
-
1QG6 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with NAD and TCL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1QG6 OCA].
+
1QG6 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=NAD:'>NAD</scene> and <scene name='pdbligand=TCL:'>TCL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1QG6 OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Escherichia coli]]
[[Category: Escherichia coli]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Pauptit, R.A.]]
+
[[Category: Pauptit, R A.]]
[[Category: Rowsell, S.]]
[[Category: Rowsell, S.]]
[[Category: NAD]]
[[Category: NAD]]
Line 21: Line 21:
[[Category: fatty acid synthesis]]
[[Category: fatty acid synthesis]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 00:39:44 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:39:10 2008''

Revision as of 12:39, 21 February 2008


1qg6, resolution 1.90Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF E. COLI ENOYL ACYL CARRIER PROTEIN REDUCTASE IN COMPLEX WITH NAD AND TRICLOSAN

Overview

Triclosan is used widely as an antibacterial agent in dermatological products, mouthwashes, and toothpastes. Recent studies imply that antibacterial activity results from binding to enoyl (acyl carrier protein) reductase (EACPR, EC 1.3.1.9). We first recognized the ability of triclosan to inhibit EACPR from Escherichia coli in a high throughput screen where the enzyme and test compound were preincubated with NAD(+), which is a product of the reaction. The concentration of triclosan required for 50% inhibition approximates to 50% of the enzyme concentration, indicating that the free compound is depleted by binding to EACPR. With no preincubation or added NAD(+), the degree of inhibition by 150 nM triclosan increases gradually over several minutes. The onset of inhibition is more rapid when NAD(+) is added. Gel filtration and mass spectrometry show that inhibition by triclosan is reversible. Steady-state assays were designed to avoid depletion of free inhibitor and changes in the degree of inhibition. The results suggest that triclosan binds to E-NAD(+) complex, with a dissociation constant around 20-40 pM. Triclosan follows competitive kinetics with respect to NADH, giving an inhibition constant of 38 pM at zero NADH and saturating NAD(+). Uncompetitive kinetics are observed when NAD(+) is varied, giving an inhibition constant of 22 pM at saturating NAD(+). By following regain of catalytic activity after dilution of EACPR that had been preincubated with triclosan and NAD(+), the rate constant for dissociation of the inhibitor (k(off)) is measured as 1.9 x 10(-4) s(-1). The association rate constant (k(on)) is estimated as 2.6 x 10(7) s(-1) M(-1) by monitoring the onset of inhibition during assays started by addition of EACPR. As expected, the ratio k(off)/k(on) = 7.1 pM is similar to the inhibition constants from the steady-state studies. The crystal structure of E. coli EACPR in a complex with coenzyme and triclosan has been determined at 1.9 A resolution, showing that this compound binds in a similar site to the diazaborine inhibitors. The high affinity of triclosan appears to be due to structural similarity to a tightly bound intermediate in catalysis.

About this Structure

1QG6 is a Single protein structure of sequence from Escherichia coli with and as ligands. Active as [acyl-carrier-protein_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number 1.3.1.9 Full crystallographic information is available from OCA.

Reference

Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan., Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA, Mistry A, Timms D, Camble R, Hales NJ, Britton CJ, Taylor IW, Biochemistry. 1999 Sep 21;38(38):12514-25. PMID:10493822 [[Category: Enoyl-[acyl-carrier-protein] reductase (NADH)]]

Page seeded by OCA on Thu Feb 21 14:39:10 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools